解锁「诱导多能干细胞iPSC」培养及前沿应用，重磅培养基新品尝鲜等您来

Core Viewpoint - OriCell, a subsidiary of Saiye, focuses on cell biology, particularly in the development and optimization of cell culture media and stem cell technology services, aiming to enhance cell cultivation practices [1][18]. Group 1: iPSC Research and Challenges - Induced pluripotent stem cells (iPSCs) hold immense potential for disease treatment, drug screening, and personalized medicine, but they are sensitive to culture conditions, making their cultivation challenging [3][4]. - The complexity and high cost of culture media, along with variability in iPSC batches, can affect differentiation efficiency, proliferation rates, and genetic stability, impacting experimental reproducibility [3][4]. Group 2: Upcoming Event and Product Launch - Saiye will host a cloud classroom on June 24, 2025, focusing on iPSC cultivation methods and applications, featuring the launch of the new "Saiye OriCell iPSC Complete Culture Medium" [4][6]. - The new iPSC Complete Culture Medium is designed to maintain high cell quality and differentiation potential, even after multiple passages, and is free from serum and animal-derived components [11][7]. Group 3: Comprehensive Service Platform - Saiye has developed a one-stop technical service platform for iPSCs, integrating reprogramming, gene editing, and in vitro differentiation technologies, providing a complete solution from disease model construction to detection [14][13]. - The platform aims to facilitate the transition from basic research to clinical applications, accelerating the development of disease research [14]. Group 4: Product Offerings and Promotions - OriCell has a comprehensive collection of stem cell lines and culture media, with ongoing promotions such as "buy three get one free" for mesenchymal stem cell culture media [16]. - The company emphasizes its commitment to providing high-quality products and services, supported by extensive research and customer feedback [16].